Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/82728
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPlummer, M.-
dc.contributor.authorMeier, J.-
dc.contributor.authorDeane, A.-
dc.date.issued2013-
dc.identifier.citationCritical Care (UK), 2013; 17(4):163-1-163-2-
dc.identifier.issn1466-609X-
dc.identifier.issn1364-8535-
dc.identifier.urihttp://hdl.handle.net/2440/82728-
dc.description.abstractEnteral nutrient is a potent glucagon-like peptide-1 (GLP-1) secretagogue. In vitro and animal studies indicate that GLP-1 has immune-modulatory and neuroprotective effects. To determine whether these immune-modulatory and neuroprotective effects of GLP-1 are beneficial in the critically ill, studies achieving pharmacological GLP-1 concentrations are warranted.-
dc.description.statementofresponsibilityMark P Plummer, Juris J Meier and Adam M Deane-
dc.description.urihttp://link.springer.com/article/10.1186%2Fcc12758-
dc.language.isoen-
dc.publisherCurrent Science Ltd-
dc.rights© 2013 BioMed Central Ltd-
dc.source.urihttp://dx.doi.org/10.1186/cc12758-
dc.subjectHumans-
dc.subjectEnteral Nutrition-
dc.subjectImmunity, Cellular-
dc.subjectIntensive Care Units-
dc.subjectFemale-
dc.subjectMale-
dc.subjectGlucagon-Like Peptide 1-
dc.titleThe gut-brain axis in the critically ill: is glucagon-like peptide-1 protective in neurocritical care?-
dc.typeJournal article-
dc.identifier.doi10.1186/cc12758-
pubs.publication-statusPublished-
dc.identifier.orcidPlummer, M. [0000-0002-9640-1911]-
dc.identifier.orcidDeane, A. [0000-0002-7620-5577]-
Appears in Collections:Anaesthesia and Intensive Care publications
Aurora harvest 4

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.